We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Urology

Journal Scan / Research · May 13, 2014

Destruction of the Bladder by Single-Dose Mitomycin C for Transitional Cell Carcinoma

BJU International


Additional Info

Disclosure statements are available on the authors' profiles:

BJU International
Destruction of the Bladder by Single Dose Mitomycin C for Low-Stage Transitional Cell Carcinoma (TCC) - Avoidance, Recognition, Management and Consent
BJU Int 2014 May 01;113(5b)E34-E38, MH Elmamoun, TJ Christmas, CR Woodhouse

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading